1. Home
  2. PULM vs HYPG Comparison

PULM vs HYPG Comparison

Compare PULM & HYPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pulmatrix Inc.

PULM

Pulmatrix Inc.

HOLD

Current Price

$1.50

Market Cap

5.3M

Sector

Health Care

ML Signal

HOLD

HYPG

Grayscale Hyperliquid Staking ETF

N/A

Current Price

$21.07

Market Cap

5.2M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
PULM
HYPG
Founded
2003
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3M
5.2M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
PULM
HYPG
Price
$1.50
$21.07
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
31.1K
31.8K
Earning Date
05-14-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
46.18
N/A
EPS
N/A
N/A
Revenue
$7,910,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
5069.93
N/A
52 Week Low
$1.16
$21.88
52 Week High
$7.20
$24.55

Technical Indicators

Market Signals
Indicator
PULM
HYPG
Relative Strength Index (RSI) 62.98 N/A
Support Level $1.21 N/A
Resistance Level $1.55 N/A
Average True Range (ATR) 0.11 0.00
MACD 0.02 0.00
Stochastic Oscillator 77.50 0.00

Price Performance

Historical Comparison
PULM
HYPG

About PULM Pulmatrix Inc.

Pulmatrix Inc is a biopharmaceutical company focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

Share on Social Networks: